Gynecology

Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss individualizing treatment decisions in girls with central precocious puberty (CPP).

Helen C. Wang, MD, shares key takeaways from the session she co-presented at PAS 2022.

A cross-sectional study of more than 70k women suggests those with long or irregular menstrual cycles were at a 22% greater risk of NAFLD.

Family history assessment, genetic screening are key to prevention.

The FDA issued an updated letter to health care providers regarding reprocessed urological endoscopes manufactured by Karl Storz.

A higher childhood body mass index (BMI) was linked to a significantly greater risk of premenstrual disorders (PMDs) and premenstrual symptoms in young adulthood compared to children with normal BMI, according to a prospective cohort study in JAMA Network Open.

A study published in the Journal of Ovarian Research examines factors that may cause endometriosis to progress to ovarian cancer.

Greg Marchand, MD, talks about his recently published article evaluating the underused potential of combined laparoscopic salpingectomy and endometrial ablation for treatment of abnormal uterine bleeding and desired sterilization.

Experts take a look at 2 cases to understand abnormal uterine bleeding in adolescents and provide a useful screening tool.

Torsion of adnexal structures can occur in pregnant women, women post-hysterectomy, and postmenopausal women.

A report provides information on how gender-affirming care such as the use of puberty blockers can positively impact the mental health of transgender and nonbinary teenagers and young adults.

Polycystic ovary syndrome (PCOS) and type 2 diabetes have some markers that suggest a connection, with PCOS patients exhibiting certain symptoms at greater risk of developing type 2 diabetes later. A systematic review examines the prevalence of the 2 conditions occurring in adolescent girls.

At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.

At the 2022 virtual SMFM conference, a poster session highlighted a study on prenatal ultrasound findings in pregnant women with SARS-CoV-2 infection.

The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.

A literature search revealed there is no international agreement on how to characterize or classify endometriosis.

Often based on racial/ethnic, socioeconomic, and age-based assumptions

Although the hysterosalpingogram (HSG) is the oldest special radiologic procedure, first performed over 110 years ago, it remains an essential part of the evaluation of the infertile couple.

Consensus group discussion resulted in a shift from results-based to risk-based management for cervical cancer screening.

A study published January 6, 2022 showed that COVID-19 vaccinations may temporarily cause changes to the timing of menstruation.

While it has been nearly 50 years since vaginal dilators were introduced as a therapy to decrease VS, the medical community still knows very little about the potential impact on long term outcomes.

Much innovation has taken place in the field of minimally invasive gynecologic surgery in the last decade. Enthusiasm for single-port surgery has waned over the past decade, due to factors like Reimbursement issues and technical demand led to a decrease in enthusiasm, but robotics companies continue to develop new solutions.

While sacrocolpopexy has been the gold standard for the anatomical correction of pelvic organ prolapse for more than three decades, it is a technically challenging procedure that results in dividing the pelvis by mesh material and often requires extensive bowel manipulation.

Women are less likely to be diagnosed with bladder cancer, but that does not make the disease any less fatal for this population of patients.